Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for April 08, 2010 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Kavapoint Introduces "Drugs & Medication PRO" for the iPad!
Kavapoint extends their line of popular iPhone apps with a new iPad version of their #1 medical app "Drugs & Medications" 
x-small text small text medium text large text


Kavapoint LogoKavapoint Logo
Drugs and Medication IconDrugs and Medication Icon
    SUNNYVALE, CA, April 08, 2010 /24-7PressRelease/ -- This week, Kavapoint released their first medical app for the iPad. This introduction makes Kavapoint one of the first developers of medical apps for the iPad!

Kavapoint is a leading developer of mobile applications with multiple top 100 medical apps in the appstore. As a leading mobile developer for medical apps, they continue to add medical apps to their portfolio specifically for iPhone, iPod Touch, and iPad applications. This new app is designed to use the larger screen size and is optimized specifically for the iPad. Kavapoint strives to innovate in the mobile medical field with more groundbreaking apps.

FEATURES
- Over 6000+ drugs
- Alphabetized Index
- Support for Landscape mode for FDA Label
- NO INTERNET REQUIRED for Description, Usage, Contraindications, MORE!
- Each listing has the brand name and generic name
- Now including Drug Manufacturer info
- Now including Route of Administration and Drug Form
- Now including the unique NDC#
- More drug names from other countries
- Addition of Drug Manufacturer in the main page
- Detailed information regarding their usage
- Ability to save favorites
- Email capability

ADVANCED SEARCH
- Advanced Search capability by name or by keyword
- Improved Search Capability to search for any keyword
- Search Filter options for name only search for faster search
- Magnify Font Size button

ONLINE RESOURCES
- FDA label for available for most drugs and is retrieved directly from the FDA
- FDA SafetyWatch for the latest FDA press releases

Drugs & Medications is already the #1 medical iPhone app in multiple countries [as of March 2010]. The introduction of "Drugs and Medications PRO" for the iPad follows the history of top selling apps in the appstore including:

- Drugs & Medications: Over 6000 drugs in the database
- ICU Pearls: Pearls of wisdom for every doctor and nurse in critical care
- On Call Notes: The app for physicians who have on-call duties
- iEmergency+: The top selling In Case of Emergency application
- iEmergency Pro: The popular family version of iEmergency

"Drugs & Medications PRO" for the iPad is now available on the appstore: http://bit.ly/drugmed4ipad

Kavapoint is is a leading developer of mobile iPhone Applications. Our mission is to develop products that reduce our stress and improve our lives. Simply put: "We make Apps to Make Life Better". For further information, please contact us at contact@kavapoint.com


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Joseph Mao:
Other Press Release Headlines:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Joseph Mao
KAVAPOINT

VP Marketing
TBD Address at this time
Sunnyvale, CA
United States 94086
Voice: 408 898 2484
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.